Is Elevance Health Inc. (ELV) a Buy, Sell, or Hold?
NYSE : ELV
Elevance Health Inc. — Analyst Ratings
$385.73 USD
$7.37 (1.95%)
- Volume
- 1.23M
- Average Volume
- 1.7M
- Market Capitalization
- $83.65B
- P/E Ratio
- 17.14
- Dividend Yield
- 1.78%
- Price Target
- $452.50
- Year High
- $436.24
- Year Low
- $273.71
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.30
- Current Ratio
- $1.52
Analyst Consensus Summary
Consensus Rating
Neutral
38 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-14.8%
vs Current Price
Price Target
$452.50
Average TargetPrice Target Range
Lowest Target
$391.00
-1.3% DOWNSIDE
Average Target
$452.50
Median Estimate
Highest Target
$498.00
-22.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 38
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 27 | 11 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Wells Fargo | Stephen Baxter | $473 | $390.33 | 2026-07-16 06:20 AM | 21.2% |